Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9BSU

EBOV GP/Nanosota-EB1

Summary for 9BSU
Entry DOI10.2210/pdb9bsu/pdb
EMDB information44872
DescriptorEnvelope glycoprotein, Nanosota-EB1, alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total)
Functional Keywordsebov glycoprotein, nanobody, viral protein
Biological sourceEbola virus
More
Total number of polymer chains5
Total formula weight267517.32
Authors
Bu, F.,Ye, G.,Liu, B.,Li, F. (deposition date: 2024-05-13, release date: 2024-12-18, Last modification date: 2025-01-29)
Primary citationBu, F.,Ye, G.,Morsheimer, K.,Mendoza, A.,Turner-Hubbard, H.,Herbst, M.,Spiller, B.,Wadzinski, B.E.,Eaton, B.,Anantpadma, M.,Yang, G.,Liu, B.,Davey, R.,Li, F.
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection.
Plos Pathog., 20:e1012817-e1012817, 2024
Cited by
PubMed Abstract: The Ebola filovirus (EBOV) poses a serious threat to global health and national security. Nanobodies, a type of single-domain antibody, have demonstrated promising therapeutic potential. We identified two anti-EBOV nanobodies, Nanosota-EB1 and Nanosota-EB2, which specifically target the EBOV glycoprotein (GP). Cryo-EM and biochemical data revealed that Nanosota-EB1 binds to the glycan cap of GP1, preventing its protease cleavage, while Nanosota-EB2 binds to critical membrane-fusion elements in GP2, stabilizing it in the pre-fusion state. Nanosota-EB2 is a potent neutralizer of EBOV infection in vitro and offers excellent protection in a mouse model of EBOV challenge, while Nanosota-EB1 provides moderate neutralization and protection. Nanosota-EB1 and Nanosota-EB2 are the first nanobodies shown to inhibit authentic EBOV. Combined with our newly developed structure-guided in vitro evolution approach, they lay the foundation for nanobody-based therapies against EBOV and other viruses within the ebolavirus genus.
PubMed: 39715280
DOI: 10.1371/journal.ppat.1012817
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.36 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon